The guidelines recommend that infectious diseases consultation (where available) be obtained before any investigational treatment is offered to a patient with COVID-19 outside of a clinical trial, and that informed consent be obtained from the patient or substitute decision-maker.
The guidelines recommend that infectious diseases consultation (where available) be obtained before any investigational treatment is offered to a patient with COVID-19 outside of a clinical trial, and that informed consent be obtained from the patient or substitute decision-maker.
